It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

  title={It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group},
  author={John H. Krystal and Lori L. Davis and Thomas C. Neylan and Murray Raskind and Paula P Schnurr and Murray B. Stein and Jennifer C. Vessicchio and Brian Shiner and Theresa D. Gleason and Grant D. Huang},
  journal={Biological Psychiatry},

Tables from this paper

Remediation of PTSD in a Combat Veteran: A Case Study

The posttraumatic stress disorder (PTSD) condition is a systemic neuroinflammatory state that emanates from a failure to recover from traumatic occurrence(s). Major complications associated with PTSD

Treatment Resistance in Post-traumatic Stress Disorder

  • A. McFarlane
  • Psychology
    Treatment Resistance in Psychiatry
  • 2018
It is argued that a staging model of PTSD will lead to more systematic research into the treatment of PTSD and assist in strategies to develop treatment resistance such as a personalised medicine approach.

Advancement Of A Valid Model Of Chronic PTSD And Repetitive mTBI: Implications For Pathophysiology And Drug Discovery

Establishing criteria that facilitate the discrimination between these conditions and developing new effective treatments should be a top priority and animal models are an appropriate platform for conducting such studies.

PTSD Treatment Problems at the U.S. Veterans Administration

Assertions from organizations such as the U.S. National Center for PTSD contradict the commonly cited contention that there is no “cure” for PTSD, and a review of PTSD literature reveals that the US government is not optimally serving the interests of veterans.

Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits

The clinical features and current treatments for PTSD are described, the neurobiology of symptom domains are examined, genomic advances are highlighted and translational approaches to understanding mechanisms and identifying new treatments and interventions for this devastating syndrome are discussed.

Development of a Practice Tool for Primary Care Providers: Medication Management of Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury

This pocket card provides PCPs an easy to carry and user-friendly clinical decision-making tool to effectively treat veterans with PTSD and comorbid mTBI.

Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries

High prescription rates and extensive use of sedative medication suggest a symptom-driven prescription that can only be explained to a minor extent by existing comorbidities, which underlines the need for effective pharmacological and psychological treatment options in psychiatric inpatient settings.

Treatment of military-related post-traumatic stress disorder: challenges, innovations, and the way forward

Factors associated with the development of PTSD in this population are examined, issues relating to engagement in treatment are considered, and the empirical support for best practice evidence-based treatment is discussed.



Post-traumatic stress disorder in the general population. Findings of the epidemiologic catchment area survey.

Findings on the epidemiology of post-traumatic stress disorder in 2493 participants examined as part of a nationwide general-population survey of psychiatric disorders show Behavioral problems before the age of 15 predicted adult exposure to physical attack and (among Vietnam veterans) to combat, as well as the development ofPost- traumatic stress disorder among those so exposed.

Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.

Prazosin was not effective in treating PTSD symptoms, improving sleep, or reducing alcohol consumption overall in this dually diagnosed group, which suggests that the presence of a comorbid condition affects the efficacy of this medication.

Treatment of recent trauma survivors with benzodiazepines: a prospective study.

The early administration of benzodiazepines to trauma survivors with high levels of initial distress did not have a salient beneficial effect on the course of their illness, while reducing physiologic expression of arousal.

Biological studies of post-traumatic stress disorder

This Review attempts to present the current state of understanding of post-traumatic stress disorder on the basis of psychophysiological, structural and functional neuroimaging, and endocrinological, genetic and molecular biological studies in humans and in animal models.

Animal Models of PTSD: A Critical Review.

This review discusses the widely used animal models of PTSD in rodents, and overviews their strengths and weaknesses in terms of face, construct, and predictive validity.

Posttraumatic stress disorder in the National Comorbidity Survey.

Progress in estimating age-at-onset distributions, cohort effects, and the conditional probabilities of PTSD from different types of trauma will require future epidemiologic studies to assess PTSD for all lifetime traumas rather than for only a small number of retrospectively reported "most serious" traumAs.

Prescribing trends in veterans with posttraumatic stress disorder.

The findings illustrate the limitations of administrative data and point to a need to supplement this work with a qualitative examination of PTSD prescribing from interviews with providers to better understand the strategies used to make medication management decisions.

Declining benzodiazepine use in veterans with posttraumatic stress disorder.

OBJECTIVE Clinical practice guidelines issued by the US Department of Veterans Affairs (VA) and the Department of Defense caution against benzodiazepine use among veterans with posttraumatic stress

Course of Posttraumatic Stress Disorder 40 Years After the Vietnam War: Findings From the National Vietnam Veterans Longitudinal Study.

The prevalence, course, and comorbidities of war-zone posttraumatic stress disorder (PTSD) across a 25-year interval are determined and underscore the need for mental health services for many decades for veterans with PTSD symptoms.